Showing results (191-200 of 228) with videos related to
Sort By:
Pageof 23
Blood|July 27, 2016
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphomaAnita Kumar, Carla Casulo, Joachim Yahalom, et al.Lancet (London, England)|June 11, 2017
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trialH Miles Prince, Youn H Kim, Steven M Horwitz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell LymphomaJacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin LymphomaPallawi Torka, Tatyana Feldman, Kerry J Savage, et al.Clinical Lymphoma, Myeloma & Leukemia|February 18, 2017
Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United StatesEric D Hsi, Steven M Horwitz, Kenneth R Carson, et al.The Pediatric Infectious Disease Journal|September 14, 2022
Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 InfectionLaura D Zambrano, Kathleen N Ly, Ruth Link-Gelles, et al.Blood Cancer Journal|June 14, 2018
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assayAndrew M Intlekofer, Erel Joffe, Connie L Batlevi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2019
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II StudyMichael S Khodadoust, Alain H Rook, Pierluigi Porcu, et al.Blood Cancer Journal|March 24, 2026
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective studyMatthew Hamby, Brian L Egleston, Zachary A K Frosch, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 15, 2013
Non-Hodgkin's lymphomas, version 1.2013Andrew D Zelenetz, William G Wierda, Jeremy S Abramson, et al.Pageof 23